Arctostaphylos Uva Ursi

Arctostaphylos uva-ursi  Spreng.

1. Taxonomic, Nomenclature & Therapeutic Summary Table

Botanical Attribute Pharmacognostic & Therapeutic Specification
Family Ericaceae.
Habitat Native to North America, Europe and Asia.
English Bearberry.
Unani Inbud-dub, Angur-e-khiras, Reechh Daakh.
Action Astringent, dirutic; used for urinary tract infections, dysuria, cystitis, urethritis, pyelitis.
Taxonomic Cohort Genus Arctostaphylos (1 documented species); Family Ericaceae (8 documented species).

2. Classical Nomenclature, Taxonomy & Biogeographical Context

Arctostaphylos uva-ursi (taxonomically cited with authority Spreng.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Ericaceae (primary family classification: Ericaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. Within botanical taxonomy, this taxon is cataloged directly under its primary accepted binomial without secondary botanical synonyms. Biogeographically, its documented habitat and ecological distribution span: Native to North America, Europe and Asia.

Across classical and vernacular Indian systems of medicine, Arctostaphylos uva-ursi is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Bearberry; in the Unani-Tibb materia medica (recorded in The National Formulary of Unani Medicine and CCRUM literature) as Inbud-dub, Angur-e-khiras, Reechh Daakh. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.

3. Therapeutic Actions, Phytochemistry & Pharmacological Profile

In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Arctostaphylos uva-ursi are: Astringent, dirutic; used for urinary tract infections, dysuria, cystitis, urethritis, pyelitis. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.

Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Arctostaphylos uva-ursi establish the following evidence base: The leaves gave 0.8–1% of a flavanol glucoside, isoquercitin, arbutin and methyl arbutin. Total arbutin content varies from 7.5 to 10.7%; tannins 15 to 20%. Arbutin hydrolyses to hydroquinone, a urinary antiseptic. Arbutin is antimicrobial, but the crude extract of uva-ursi is more effective than isolated arbutin. In rats, uvaursi showed anti-inflammatory activity against experimentally induced inflammation. (Natural Medicines comprehensive Database, 2007.)

image2

Botanical Reference 1: Arctostaphylos uva-ursi — Botanical specimen

image3

Botanical Reference 2: Arctostaphylos uva-ursi — Botanical specimen

image4

Botanical Reference 3: Arctostaphylos uva-ursi — Wikimedia Commons reference

4. Comparative Genus & Family Pharmacognosy

Within Indian medicinal flora, Arctostaphylos uva-ursi stands as a distinct representative of the genus Arctostaphylos. Its therapeutic profile underscores the role of selectively utilized medicinal genera alongside larger polytypic genera.

At the family level, Ericaceae encompasses 8 documented medicinal species (0.44% of the 1,814-species flora). Other representative medicinal members of Ericaceae include: Gaultheria fragrantissima (Gandhapuura), Lyonia ovalifolia (Angyaar), Rhododendron anthopogon (Taalisri), Rhododendron arboreum (Tree-Rhododendron). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

image1

Figure 1: Quantitative documentation profile across all 8 medicinal species of family Ericaceae.

5. Pharmacopoeial Standards, Posology & Reference Framework

In clinical and traditional dispensing, preparation and administration of Arctostaphylos uva-ursi follow the plant-part modalities specified under its therapeutic action (Astringent, dirutic; used for urinary tract infections, dysuria, cystitis, urethritis, pyelitis), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Arctostaphylos uva-ursi integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.

Scroll to Top